Skip to content

Ayurvedic treatment for Metabolic Syndrome a disease which includes obesity, elevated blood pressure, abnormal lipids with early diabetes at one place

Ayurvedic formulation developed for the prevention and management of Metabolic syndrome and cardiovascular risk

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005899
Enrollment
1000
Registered
2015-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Metabolic syndrome

Interventions

Intervention1: Test formulation containing hydro-alcoholic extract of Salacia parviflora, Tribulus terrestris and Dioscorea glabra in the dose of 500mg twice per day for a period of 6 months.: The tes

Sponsors

Adesh University
Lead Sponsor
Dr H S Gill
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Triglycerides >150 mg% 2. Abdominal girth Male > 102 cm and Female > 85 cm 3. BP systolic > 130 mm Hg and Diastolic > 85 mm Hg 4. HDL 5. Fasting Blood Sugar > 100 mg%

Exclusion criteria

Exclusion criteria: 1. FBS 2. TG 3. BP Systolic

Design outcomes

Primary

MeasureTime frame
The impact of Ayurvedic formulation on body mass index, lipid profile, blood pressure, leptin and adiponectin level.Timepoint: A gradual improvement was noticed in the abnormalities associated with metabolic syndrome. The most effective results were obtained at the end of six months of treatment.

Secondary

MeasureTime frame
Modified atherogenic dyslipidemia along with improvement in feeling of well being and work performance was noticed.Timepoint: A gradual improvement was noticed in the abnormalities associated with metabolic syndrome. The most effective results were obtained at the end of six months of treatment.

Countries

India

Contacts

Public ContactDr Rakendra Singh

Adesh Institute of Medical Sciences and Research

gpdubey13@gmail.com09450963942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026